Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013


Discovery Chemistry & Drug Design Congress 2013

10 Jun 2013 - 11 Jun 2013 - Geneva, Switzerland



Bookmark and Share


Oxford Global Conferences are proud to present the Discovery Chemistry & Drug Design Congress taking place on 10 & 11 June in Geneva. This congress is the latest addition to our long-established 14th Annual Drug Discovery Summit. Focused on the latest breakthroughs in discovery chemistry, it will bring together the industry leaders in medicinal chemistry and drug design.

The discovery industry faces a decade of monumental change – stem cell research, gene therapy approvals, virtual R&D models and a growing focus on biological pipelines are just a few of the factors changing the way we approach drug discovery. Our expert speaker panel will explore the critical concerns in discovery chemistry today, while updating key decision makers on the latest developments in drug design.

Day One will feature presentations on lead optimisation, structure-activity relationships and fragment-based drug discovery. Our internationally renowned speakers will also discuss the latest developments in drug design, including anti-target modelling, advances in polypharmacology and structure based design.

The event will be co-located with the Innovation Driven Discovery Congress; a high-level meeting focused on novel approaches to drug discovery and collaborative working methods. Delegates will also be able to attend the co-located Drug Development Congress; a two stream event for those working at the forefront of research, development and translational medicine.



Further information
Scientific News
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Honey’s Potential to Save Lives
The healing powers of honey have been known for thousands of years.
3-D Printed Lifelike Liver Tissue for Drug Screening
A team led by engineers at the University of California, San Diego has 3D-printed a tissue that closely mimics the human liver's sophisticated structure and function. The new model could be used for patient-specific drug screening and disease modeling.
Cytoskeleton Crew
Findings confirm sugar's role in helping cancers survive by changing cellular architecture.
Biomarker for Recurring HPV-Linked Oropharyngeal Cancers
A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!